Exceptional care, groundbreaking research
The Washington University NF Center is focused on accelerating the pace of scientific discovery and its application to the care of individuals with NF.
The 2017 International NF1 Autism Workshop was organized by Dr. Stephanie M. Morris, Co-Director of the St. Louis Children's Hospital NF Clinical Program. Under her leadership, the INFACT group planned the next-phase studies aimed at understanding autism in NF1. In addition, new initiatives were also discussed, including the creation of a centralized database and the adoption of standardized screening guidelines for children with NF1.
Trevor’s family did not know he had NF1 until he was 2 years old, a chance encounter with a stranger initiated their path to diagnosis. Since that time, Trevor’s family has become a great support system for his development and cultivating his positive attitude towards life. Learn more about Trevor and his journey with NF1, from his loving sister in our latest Patient Spotlight article.
Children with NF1 are at risk for developing brain tumors. While much is known about the more common optic pathway gliomas, comparatively less is known about NF1-associated brainstem gliomas. To learn more about these tumors, Dr. Jasia Mahdi and her colleagues worked with investigators at Lurie Children’s Hospital in Chicago, Children’s Hospital of Philadelphia, and Children’s National Medical Center in Washington DC.
Jun 16, 2017
Children with Neurofibromatosis type 1 (NF1) have a higher risk of developing autism spectrum disorder than their unaffected peers. Based...
Jun 2, 2017
Children with NF1 are at risk for developing brain tumors, which most commonly are located within the optic pathway, the...
May 15, 2017
Corina Anastasaki, PhD has recently been promoted to the role of Senior Research Scientist in the Gutmann laboratory. Dr. Anastasaki...